急性冠状动脉综合征的当代风险分层
Gurleen Kaur1, Swati Chand2, Devesh Rai3
1Department of Internal Medicine, Brigham and Women's Hospital Boston, MA.
在急诊室评估胸痛需要风险分层来确定急性冠状动脉综合征. 2021年的指导方针提供了确定胸痛患者需要进一步测试的途径.
科学领域:
- 心脏病学 心脏病学
- 紧急医疗 紧急医疗
背景情况:
- 胸痛是急诊室常见的抱怨,原因多种多样,包括急性冠状动脉综合征.
- 最初的评估包括症状表征和风险因素的识别.
研究的目的:
- 对急性冠状动脉综合征的当代风险分层方法进行审查.
- 为了总结2021年美国心脏协会/美国心脏病学会关于胸痛评估的指南.
主要方法:
- 利用临床决策途径和心脏热素生物标志物进行风险分层.
- 应用2021年急性胸痛评估指南中的建议.
主要成果:
- 当代风险分层确定了不需要进一步测试,立即心脏导管或进一步解剖/功能测试的患者子组.
- 2021年准则为评估急性胸痛患者提供了一个框架.
结论:
- 有效的风险分层对于治疗急性胸痛患者至关重要.
- 2021年指南为胸痛评估和诊断提供了一种标准化的方法.
更多相关视频
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
相关概念视频
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Imaging Studies for Cardiovascular System V: CT
Cardiovascular Drugs: Classification based on Therapeutic Indications
